Get the app!
Back to Trades

BERENDT MICHAEL J

DirectorCIK 0001186877

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
3
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

BERENDT MICHAEL J, Director, has filed 3 SEC reports (2026), all concentrated in Retension Pharmaceuticals, Inc. (RTSN), totaling $67.6K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

3 loaded
Oct 13RTSN
Retension Pharmaceuticals, Inc.
BERENDT MICHAEL JDirectorConversion$0
Oct 8RTSN
Retension Pharmaceuticals, Inc.
BERENDT MICHAEL JDirectorAward$67.6K
Oct 8RTSN
Retension Pharmaceuticals, Inc.
BERENDT MICHAEL JDirectorOther$0

3 filings